ConductScience.org, home

Paper36768491

Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast.

Takahashi C and 4 others. Int J Mol Sci, 2023. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast. Papers, record 36768491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768491

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.37
iCite
Revised in PubMed
2023-02-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takahashi CChisatohttps://orcid.org/0000-0002-7215-8726
2Oishi MMariko
3Iwata YYuko
4Maekawa KKeikohttps://orcid.org/0000-0003-4857-4137
5Matsumura TTsuyoshihttps://orcid.org/0000-0001-6241-3626

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Muscular DystrophiesMajor topic
Heart FailureMajor topic
CardiomyopathiesMajor topic
Humans
ortho-Aminobenzoates
Biomarkers
TRPV Cation Channels

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
H28-NHO(Shinkei)-01Grant-in-Aid for Clinical Research from the National Hospital OrganizationPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119050039Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.Hum Mol Genet2009https://conductscience.org/library/papers/19050039PubMed
230006121Urinary prostaglandin metabolites as Duchenne muscular dystrophy progression markers.Brain Dev2018https://conductscience.org/library/papers/30006121PubMed
312480795Omega-3 fatty acids in inflammation and autoimmune diseases.J Am Coll Nutr2002https://conductscience.org/library/papers/12480795PubMed
41282575Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages.Jpn J Pharmacol1992https://conductscience.org/library/papers/1282575PubMed
531394715Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy.Int J Mol Sci2019https://conductscience.org/library/papers/31394715PubMed
625988613Current understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophy.Molecules2015https://conductscience.org/library/papers/25988613PubMed
712588785Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.Arterioscler Thromb Vasc Biol2003https://conductscience.org/library/papers/12588785PubMed
817993463Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.J Biol Chem2008https://conductscience.org/library/papers/17993463PubMed
923603101A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years old.Clin Chim Acta2013https://conductscience.org/library/papers/23603101PubMed
1020303788Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia.J Ren Nutr2010https://conductscience.org/library/papers/20303788PubMed
1131896817Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models.Lab Invest2020https://conductscience.org/library/papers/31896817PubMed
1211133172Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how?Prostaglandins Leukot Essent Fatty Acids2000https://conductscience.org/library/papers/11133172PubMed
1320689756Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.Neoplasia2010https://conductscience.org/library/papers/20689756PubMed
1412469901Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy.Scand J Clin Lab Invest2002https://conductscience.org/library/papers/12469901PubMed
1516009351Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells.Biochem Pharmacol2005https://conductscience.org/library/papers/16009351PubMed
1623786999Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy.Cardiovasc Res2013https://conductscience.org/library/papers/23786999PubMed
1714698037COX-2-mediated PGD2 synthesis regulates phosphatidylcholine biosynthesis in rat renal papillary tissue.Biochem Pharmacol2004https://conductscience.org/library/papers/14698037PubMed
1819474179omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.Cardiovasc Res2009https://conductscience.org/library/papers/19474179PubMed
1921561620Effect of n-3 fatty acids and statins on oxidative stress in statin-treated hypercholestorelemic and normocholesterolemic women.Atherosclerosis2011https://conductscience.org/library/papers/21561620PubMed
2023188550Cyclooxygenase-2 expression in skeletal muscle of knockout mice suffering Duchenne muscular dystrophy.Histochem Cell Biol2013https://conductscience.org/library/papers/23188550PubMed

See all 40 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41511297Tranilast Does Not Inhibit TRPV2.Cells2025https://conductscience.org/library/papers/41511297PubMed
40011677Urinary prostaglandin D2 and E2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy.Sci Rep2025https://conductscience.org/library/papers/40011677PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
NPPB4879PubTator's text mininghttps://conductscience.org/library/genes/4879NCBI Gene
PTGDS5730PubTator's text mininghttps://conductscience.org/library/genes/5730NCBI Gene
PTGS25743PubTator's text mininghttps://conductscience.org/library/genes/5743NCBI Gene
TRPV251393PubTator's text mininghttps://conductscience.org/library/genes/51393NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36768491

GET https://conductscience.org/api/papers/v1/36768491/references?page=2